Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Change in Accured Expenses (2020 - 2025)

Caribou Biosciences has reported Change in Accured Expenses over the past 6 years, most recently at -$2.8 million for Q4 2025.

  • Quarterly Change in Accured Expenses fell 27.59% to -$2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.3 million through Dec 2025, down 397.09% year-over-year, with the annual reading at -$6.3 million for FY2025, 397.09% down from the prior year.
  • Change in Accured Expenses was -$2.8 million for Q4 2025 at Caribou Biosciences, down from -$1.1 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $5.0 million in Q2 2024 and troughed at -$4.1 million in Q1 2023.
  • The 5-year median for Change in Accured Expenses is $57000.0 (2021), against an average of $388550.0.
  • Year-over-year, Change in Accured Expenses soared 442.86% in 2022 and then crashed 176.23% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$574000.0 in 2021, then soared by 442.86% to $2.0 million in 2022, then soared by 47.1% to $2.9 million in 2023, then crashed by 176.23% to -$2.2 million in 2024, then decreased by 27.59% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Change in Accured Expenses are -$2.8 million (Q4 2025), -$1.1 million (Q3 2025), and $688000.0 (Q2 2025).